Janney Capital Management LLC lifted its position in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) by 6.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 150,249 shares of the medical equipment provider’s stock after buying an additional 9,304 shares during the quarter. Janney Capital Management LLC owned approximately 0.07% of Zimmer Biomet worth $17,592,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ZBH. Bronfman E.L. Rothschild L.P. lifted its stake in shares of Zimmer Biomet by 25.3% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 167 shares during the last quarter. Bank of Nova Scotia Trust Co. purchased a new stake in shares of Zimmer Biomet during the 3rd quarter worth $112,000. FNY Managed Accounts LLC purchased a new stake in shares of Zimmer Biomet during the 3rd quarter worth $117,000. BB&T Investment Services Inc. purchased a new stake in shares of Zimmer Biomet during the 2nd quarter worth $144,000. Finally, Sandy Spring Bank lifted its stake in shares of Zimmer Biomet by 5.4% during the 2nd quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 66 shares during the last quarter. 86.24% of the stock is currently owned by institutional investors and hedge funds.

Zimmer Biomet Holdings Inc (NYSE:ZBH) traded up $0.13 during trading on Tuesday, reaching $113.51. The company’s stock had a trading volume of 1,144,900 shares, compared to its average volume of 1,355,405. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.78 and a current ratio of 1.47. Zimmer Biomet Holdings Inc has a 52 week low of $100.81 and a 52 week high of $133.49. The stock has a market capitalization of $22,956.40, a PE ratio of 14.05, a PEG ratio of 1.76 and a beta of 1.15.

Zimmer Biomet (NYSE:ZBH) last released its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.02). Zimmer Biomet had a net margin of 8.36% and a return on equity of 16.29%. The business had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter last year, the business posted $1.79 earnings per share. The company’s quarterly revenue was down .8% compared to the same quarter last year. equities research analysts predict that Zimmer Biomet Holdings Inc will post 8.03 EPS for the current fiscal year.

ZBH has been the subject of a number of analyst reports. Royal Bank of Canada decreased their price objective on Zimmer Biomet to $125.00 and set an “outperform” rating for the company in a research note on Tuesday, November 7th. Zacks Investment Research cut Zimmer Biomet from a “hold” rating to a “sell” rating in a research note on Monday, November 6th. BMO Capital Markets decreased their price objective on Zimmer Biomet from $140.00 to $135.00 and set an “outperform” rating for the company in a research note on Thursday, November 2nd. Jefferies Group restated a “buy” rating and set a $136.00 price objective on shares of Zimmer Biomet in a research note on Friday, November 3rd. Finally, Edward Jones upgraded Zimmer Biomet from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $133.71.

TRADEMARK VIOLATION NOTICE: “Janney Capital Management LLC Purchases 9,304 Shares of Zimmer Biomet Holdings Inc (ZBH)” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/janney-capital-management-llc-purchases-9304-shares-of-zimmer-biomet-holdings-inc-zbh/1759884.html.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with Analyst Ratings Network's FREE daily email newsletter.